Imiquimod; an international update on therapeutic uses in dermatology (Q35009563)

5 August 2017

1 reference

title

Imiquimod; an international update on therapeutic uses in dermatology (English)

1 reference

5 August 2017

Stephen Tyring

1

1 reference

5 August 2017

Marcus Conant

2

1 reference

5 August 2017

Mario Marini

3

1 reference

5 August 2017

Willem Van Der Meijden

4

1 reference

5 August 2017

Ken Washenik

5

1 reference

5 August 2017

1 November 2002

1 reference

International Journal of Dermatology

5 August 2017

1 reference

5 August 2017

41

1 reference

5 August 2017

11

1 reference

5 August 2017

810-816

1 reference

Epidemiology of Genital Human Papillomavirus Infection

5 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

Natural history of cervicovaginal papillomavirus infection in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

The psychosocial impact of human papillomavirus infection: implications for health care providers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

Counseling patients with genital warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

New patient-applied therapy for anogenital warts is rated favourably by patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

Immunomodulatory therapy in the management of viral infections in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

HIV-related skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

Cytokine profiles in spontaneously regressing basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

Treatment of multiple basal cell carcinomas in the scalp with imiquimod 5% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

The risk of progression to invasive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

Guidelines of care for actinic keratoses. Committee on Guidelines of Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

Imiquimod 5% cream in the treatment of Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

Adjunct therapies to surgical management of keloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01597.X

10.1046/J.1365-4362.2002.01597.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference